Global Genome Editing/Genome Engineering Market - Global Forecast To 2030

Share

Global Genome Editing/Genome Engineering Market - Global Forecast To 2030


 Category : Biotechnology

 Published: Feb-2022
 Author: SPER Analyst


According to SPER Market Research, the Genome Editing/Genome Engineering Market is estimated to reach USD 25.3 billion by 2030 with a CAGR of 19.5%. 

The introduction of CRISPR-Cas9, increasing government funding, growth in genomic fields; these are acting as the fuel for the expansion of this market.

Browse report overview on "Global Genome Editing/Genome Engineering Market" at: https://www.sperresearch.com/report-store/Genome-Editing-Genome-Engineering.aspx

Costly equipment, off-target effect of CRISPR-Cas9; are the short-term challenges to this genome editing market.

Due to the rising demand of personalized medicine; this market player gives huge opportunities to genome editing market player. The emerging countries are offering vast scopes in this field.

Reagents and consumables from the product & service segment are expected to dominate the growth of genome editing market.

Gene synthesis for the genetic engineering of tissue and cells, increase in the investment is the keys for the escalation of the gene editing market in Asia Pacific region.

North America has the prime share of this genome editing market; it is because of growing exploitation of genetically modified crops, gene therapy, government grants and funding.

The global Genome Editing/Genome Engineering Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Agilent Technologies, Beam Therapeutics , Bluebird Bio, Caribou Biosciences., Cellectis S.A, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, GenScript, Integrated DNA Technologies, Intellia Therapeutics, Lonza, Merck KGaA, New England Biolabs, OriGene Technologies, PerkinElmer, Precision Biosciences, Recombinetics, Regeneron Pharmaceuticals, Sangamo Therapeutics, Synthego, Tecan Life Sciences, Thermo Fisher Scientific, Transposagen, Biopharmaceuticals, Vigene Biosciences.

Request sample pages for Global Genome Editing/Genome Engineering Market report and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Genome-Editing-Genome-Engineering.aspx?sample=1

SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product & Service segment- Reagents & consumables, Services, Software & systems, for Application segments- Cell Line Engineering, Diagnostic applications, Drug discovery & development, Genetic Engineering, for Technology segment- Antisense, CRISPR, TALEN, ZFN, and for End-Users segment- Academic & Government Research Institutes, Biotechnology companies, Pharmaceutical companies.

This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World. 

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report. 

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us